Ativo Circulante Alterar Data
Akzo Nobel EUR 8.41B 287M 2026-09
Alcon AG USD 6.97B 350M 2026-09
AstraZeneca USD 31.45B 3.48B 2026-09
BASF EUR 35.21B 3.58B 2026-09
Bayer EUR 39.6B 5.96B 2026-09
Beiersdorf EUR 7.43B 768M 2026-06
DaVita Healthcare Partners USD 4.07B 114.82M 2026-09
Demant DKK 10.2B 130M 2026-06
E.ON EUR 28.7B 1.95B 2026-09
Essilor EUR 11.24B 770M 2026-06
Fresenius EUR 12.29B 678M 2026-09
Fresenius Medical Care EUR 7.84B 150.6M 2026-09
Getinge SEK 15.77B 2.39B 2026-06
Givaudan CHF 4.07B 258M 2025-12
GlaxoSmithKline GBP 17.9B 336M 2026-09
GN Store Nord DKK 20.15B 14.52B 2026-09
GRIFOLS EUR 5.35B 40M 2026-09
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lonza CHF 8B 3.41B 2025-12
Merck EUR 15.14B 1.37B 2026-09
Novartis USD 28.75B 1.4B 2026-09
Philips EUR 10.51B 1.18B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
RWE EUR 51.76B 10.21B 2026-09
Sanofi EUR 33.21B 1.68B 2026-09
Smith & Nephew USD 4.39B 240M 2026-06